Yoshino H, Imi T, Nukii Y, Hosokawa K, Yamada S, Nakagawa S, Higashi D, Sakai S, Fujii S, Hiratsuka A, Hatada T, Yoroidaka T, Mizumaki H, Zaimoku Y, Yoshida A, Maruyama H, Watanabe S, Ueda T, Ito Y, Horie M, Toho M, Matsue K, Takamatsu H, Miyamoto T. Parkinsonism-like delayed neurotoxicity after idecabtagene vicleucel therapy for multiple myeloma: clinicopathological, cerebrospinal fluid, and autopsy analyses. haematol [Internet]. 2020Sep.10 [cited 2026Sep.15];. Available from: https://haematologica.org/article/view/14367